title: Cost-effectiveness of private umbilical cord blood banking.
authors.affiliation: Department of Pathology, UMC Utrecht, Utrecht, the Netherlands (Nietfeld) Department of Immunobiology, University of Arizona, Tucson, Arizona (Harris).
authors.forename: J J
authors.initials: JJ
authors.lastname: Nietfeld
authors.forename: David T
authors.initials: DT
authors.lastname: Harris
mesh_terms: D036101:Cord Blood Stem Cell Transplantation / Q000191:economics*; D003362:Cost-Benefit Analysis; D005312:Fetal Blood; D017149:Private Sector / Q000191:economics; D014015:Tissue Banks / Q000191:economics*
references.citation: Kaimal AJ, Smith CC, Laros RK Jr, Caughey AB, Cheng YW. Cost-effectiveness of private umbilical cord blood banking. Obstet Gynecol 2009;114:848–55.
references.citation: Nietfeld JJ. Opinions regarding cord blood use need an update. Nat Rev Cancer 2008;8:823.
references.citation: Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM. Lifetime probabilities of hematopoietic stem cell transplantation in the U.S. Biol Blood Marrow Transplant 2008;14:316–22.
references.citation: Van Agthoven M, Vellenga E, Fibbe WE, Kingma T, Uyl-de Groot CA. Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or Hodgkin's disease. A prospective randomised trial. Eur J Cancer 2001;37:1781–9.